Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
Open Access
- 11 November 2008
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal Of Neuroradiology
- Vol. 30 (2), 404-410
- https://doi.org/10.3174/ajnr.a1357
Abstract
BACKGROUND AND PURPOSE: Patients with mild cognitive impairment (MCI) are at risk for developing Alzheimer disease (AD). To diagnose AD at an early stage, one must develop highly specific and sensitive tools to identify it among at-risk subjects. The purpose of this study was to evaluate and compare the ability of fluorodeoxyglucose–positron-emission tomography (FDG-PET), single-photon emission tomography (SPECT), and structural MR imaging to predict conversion to AD in patients with MCI.Keywords
This publication has 34 references indexed in Scilit:
- Meta‐Analysis MethodsAdvances in genetics, 2008
- Meta-DiSc: a software for meta-analysis of test accuracy dataBMC Medical Research Methodology, 2006
- Heterogeneity of Brain Glucose Metabolism in Mild Cognitive Impairment and Clinical Progression to Alzheimer DiseaseArchives of Neurology, 2005
- The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviewsBMC Medical Research Methodology, 2003
- Mild cognitive impairmentNeurology, 2003
- Mild cognitive impairment: prevalence, prognosis, aetiology, and treatmentThe Lancet Neurology, 2003
- Current Concepts in Mild Cognitive ImpairmentArchives of Neurology, 2001
- Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]Neurology, 2001
- Diagnosis and Treatment of Alzheimer Disease and Related DisordersJAMA, 1997
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984